Call Us - We're Easy to Talk To (214) 999-9999

Eli Lilly to Pay $24 Million in Zyprexa Off-Label Marketing Suit

The AP reports, “Utah has agreed to a $24 million settlement with Eli Lilly & Co. over claims the drugmaker engaged in off-label marketing of the anti-psychotic drug Zyprexa [olanzapine],” according to Attorney General Mark Shurtleff. The drug is currently “approved for the treatment of schizophrenia and certain types of bipolar disorder,” but “the company’s sales force illegally promoted Zyprexa for uses not approved by the” FDA, including “dementia, Alzheimer’s, agitation, and depression,” he added.

The Salt Lake Tribune reports that a four-year investigation by the state revealed that “1,769 Utah Medicaid patients over age 65 took Zyprexa without the proper diagnosis.” David Sundwall, executive director of Utah’s Department of Health, said “the state’s Zyprexa tab totaled $11 million since 2007.”

The investigation also showed that “Lilly concealed its knowledge of significant weight gain and obesity associated with the antipsychotic,” the Deseret News reports. Shurtleff said that “as part of the settlement agreement, there are corporate integrity responsibilities and remedial provisions that will continue to be monitored by the court.”

From the American Association for Justice news release.

Bob Kraft

I am a Dallas, Texas lawyer who has had the privilege of helping thousands of clients since 1971 in the areas of Personal Injury law and Social Security Disability.

About This Blog

The title of this blog reflects my attitude toward those government agencies and insurance companies that routinely mistreat injured or disabled people. As a Dallas, Texas lawyer, I've spent more than 45 years trying to help those poor folk, and I have been frustrated daily by the actions of the people on the other side of their claims. (Sorry if I offended you...)

If you find this type of information interesting or helpful, please visit my law firm's main website at You will find many more articles and links. Thank you for your time.

Find us on your preferred network